Acta Pharmaceutica Sinica B
|
2025, 15(11): 6082-6086
• Highlights •
Unlocking the potential of targeted protein degradation via nanoparticle-based universal strategy
Full
Ti-Qiang Zhou1, Weilun Sun1, Zhen-Zhen Wei2, Yuhua Weng1,3,4,5, Dongxu Zhao1, Mengjie Zhang1,3,4,5, Yuanyu Huang1,3,4,5
Affiliations
1 School of Life Science, School of Interdisciplinary Science, Aerospace Center Hospital, Key Laboratory of Molecular Medicine and Biotherapy, Key Laboratory of Medical, Molecule Science and Pharmaceutics Engineering, Beijing Institute of Technology, Beijing 100081, China;
2 Integrated Chinese and Western Medicine Institute for Children Health and Drug Innovation, Institute of Chinese Medicine, Jiangxi University of Chinese Medicine, Nanchang 330004, China;
3 School of Medical Engineering, School of Interdisciplinary Science, Affiliated Zhuhai People's Hospital, Beijing Institute of Technology, Zhuhai 519088, China;
4 Advanced Technology Research Institute, Beijing Institute of Technology, Jinan 250100, China;
5 Zhengzhou Research Institute, Beijing Institute of Technology, Zhengzhou 450040, China
doi: 10.1016/j.apsb.2025.09.016
Outline
Targeted protein degradation
/
Nanoparticles
/
Cellular transport
/
Nanomedicine
/
Nanoparticle-based strategy
/
Proteins of interest
/
PROTAC
/
Lysosomes
Ti-Qiang Zhou, Weilun Sun, Zhen-Zhen Wei, Yuhua Weng, Dongxu Zhao, Mengjie Zhang, Yuanyu Huang.
Unlocking the potential of targeted protein degradation via nanoparticle-based universal strategy[J].
Acta Pharmaceutica Sinica B,
2025
, 15
(11)
: 6082
-6086
.
DOI: 10.1016/j.apsb.2025.09.016
Year 2025 volume 15 Issue 11
PDF
8
5
Cite this Article
BibTeX
Article Info
doi: 10.1016/j.apsb.2025.09.016
- Receive Date:2025-02-26
- Online Date:2026-09-17